Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
51.7M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$366M
-
Value change
-
+$10.7M
-
Put/Call ratio
-
0.01
-
Number of buys
-
80
-
Number of sells
-
-68
-
Price
-
$7.07
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2024
191 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q4 2024.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.7M shares
of 69.1M outstanding shares and own 74.84% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.58M shares), First Light Asset Management, LLC (5.24M shares), VANGUARD GROUP INC (4.39M shares), Impax Asset Management Group plc (2.75M shares), Daventry Group, LP (2.51M shares), Alyeska Investment Group, L.P. (2.02M shares), MILLENNIUM MANAGEMENT LLC (1.99M shares), WELLINGTON MANAGEMENT GROUP LLP (1.96M shares), PRIMECAP MANAGEMENT CO/CA/ (1.93M shares), and KENNEDY CAPITAL MANAGEMENT LLC (1.89M shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.